Label: GOUT RELIEF 3310-S- medicago sativa whole chicory root capsule

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: unapproved homeopathic

DISCLAIMER: This homeopathic product has not been evaluated by the Food and Drug Administration for safety or efficacy. FDA is not aware of scientific evidence to support homeopathy as effective.

Drug Label Information

Updated September 1, 2025

If you are a consumer or patient please visit this version.

  • ACTIVE INGREDIENT

    MEDICAGO SATIVA WHOLE 20.00%
    CHICORY ROOT 23.00%
    GLUCOSAMINE HYDROCHLORIDE 10.00%
    BUCKWHEAT 7.00%
    TEA LEAF 5.00%
    MORUS ALBA LEAF 13.00%
    LICORICE 0.20%
    FU LING 2.00%
    COIX LACRYMA-JOBI SEED 8.00%

  • INACTIVE INGREDIENT

    This product has a significanteffect on gout, crystal deposits,and hyperuricemia;
    elt has an auxiliary effectof mitigating kidney stonesand bladder stones

  • KEEP OUT OF REACH OF CHILDREN

    Keep out of reach of children

  • DOSAGE & ADMINISTRATION

    The product has great somatosensation after taking it atleast 21 days in the earty stage;3. Elevated uric acid or gout recurrence and site changes arenoral in the earty stage of taking this product;

  • INDICATIONS & USAGE

    Dissolved CrystallizationKidney StoneGallstone< Urinary Calculus

  • OTHER SAFETY INFORMATION

    Do not use if seal is broken.

    Do not eat freshness packet enclosed.

    Keep out of direct sunlight, high temperature, and humidity.

    Store in a cool, dry place.

  • WARNINGS

    For your health, please read the followingcarefully
    1. The use of three vials can effectivety dissolve crystallization (ittakes time to dissolve crystallization);2. The product has great somatosensation after taking it atleast 21 days in the early stage;3. Elevated uric acid or gout recurrence and site changes arenormal in the early stage of taking this product;4. Try not to drink alcohol or drink less 15 days before takingthis product;
    5. This product certainly has significant effect on gout,crystallization and hyperuricemia;

  • PURPOSE

    This product has a significanteffect on gout, crystal deposits,and hyperuricemia; elt has an auxiliary effectof mitigating kidney stonesand bladder stones

  • PRINCIPAL DISPLAY PANEL

    labeling

  • INGREDIENTS AND APPEARANCE
    GOUT RELIEF 3310-S 
    medicago sativa whole chicory root capsule
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:85631-006
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    COIX LACRYMA-JOBI SEED (UNII: 4Q4V6NTZ1F) (COIX LACRYMA-JOBI SEED - UNII:4Q4V6NTZ1F) COIX LACRYMA-JOBI SEED104 mg  in 1.3 g
    MEDICAGO SATIVA WHOLE (UNII: DJO934BRBD) (MEDICAGO SATIVA WHOLE - UNII:DJO934BRBD) MEDICAGO SATIVA WHOLE260 mg  in 1.3 g
    BUCKWHEAT (UNII: N0Y68724R3) (BUCKWHEAT - UNII:N0Y68724R3) BUCKWHEAT91 mg  in 1.3 g
    TEA LEAF (UNII: GH42T47V24) (TEA LEAF - UNII:GH42T47V24) TEA LEAF65 mg  in 1.3 g
    MORUS ALBA LEAF (UNII: M8YIA49Q2P) (MORUS ALBA LEAF - UNII:M8YIA49Q2P) MORUS ALBA LEAF169 mg  in 1.3 g
    CHICORY ROOT (UNII: 090CTY533N) (CHICORY ROOT - UNII:090CTY533N) CHICORY ROOT299 mg  in 1.3 g
    FU LING (UNII: XH37TWY5O4) (FU LING - UNII:XH37TWY5O4) FU LING26 mg  in 1.3 g
    GLUCOSAMINE HYDROCHLORIDE (UNII: 750W5330FY) (GLUCOSAMINE - UNII:N08U5BOQ1K) GLUCOSAMINE HYDROCHLORIDE130 mg  in 1.3 g
    LICORICE (UNII: 61ZBX54883) (LICORICE - UNII:61ZBX54883) LICORICE2.6 mg  in 1.3 g
    Inactive Ingredients
    Ingredient NameStrength
    MALTOSYL-ISOMALTOTETRAOSE (UNII: B9HR7A9UFR)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
    CARBOXYMETHYLCELLULOSE SODIUM (UNII: K679OBS311)  
    Product Characteristics
    ColorwhiteScorescore with uneven pieces
    ShapeCAPSULESize20mm
    FlavorImprint Code
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:85631-006-0160 in 1 BOTTLE09/01/2025
    11.3 g in 1 CAPSULE; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved homeopathic09/01/2025
    Labeler - Bispit Canada Ltd. (243332192)
    Registrant - Bispit Canada Ltd. (243332192)